Registration Number
0224U033364,
(0121U112054)
, R & D reports
Title
The development of methods for the prevention and intensive therapy of complications during complex treatment in cancer patients who have been infected by COVID-19.
popup.stage_title
Розроблення програми індивідуального комплексного лікування онкологічних хворих, які перенесли СOVID-19.
Head
Krasnoselskyi Mykola V., Доктор медичних наук
Krutko Yevhen M., д.мед.н.
Registration Date
25-12-2024
Organization
State Organization "Grigoriev Institute for Medical Radiologiy and Oncology of the National Academy of Medical Sciences of Ukraine"
popup.description1
To increase the effectiveness of comprehensive treatment of cancer patients, who have had COVID-19, by improving the methods of prevention and intensive care based on the study of metabolic and energy characteristics.
popup.description2
Research Object: Oncology patients who have undergone COVID-19, during specialized treatment. Purpose of the study: To improve the effectiveness of comprehensive treatment for oncology patients who have undergone COVID-19 by improving methods of prevention and intensive therapy based on the study of metabolic and energy characteristics. Research Methods and Equipment: Clinical-instrumental, biochemical, clinical, statistical; biochemical analyzer, immunochemical hematological analyzer; spirometry complex "Spirocom," electrocardiograph Midas 6/12, automatic blood pressure measurement device MENARINI, ultrasound diagnostic apparatus CHISON i7. Theoretical and Practical Results: The effectiveness of comprehensive treatment for oncology patients who have undergone COVID-19 was evaluated. The method of intensive therapy for oncology patients who have undergone COVID-19 was improved, and preventive measures for complications during comprehensive treatment were substantiated. Novelty: An algorithm for intensive therapy in oncology patients who have undergone COVID-19 was proposed, based on the determination of the characteristics of metabolic and energy disorders. Implementation Effectiveness: Reduction of mortality by 1,2 times; risk of massive pulmonary artery thromboembolism by 4,6 times; hypoxic myocardial damage by 3,1 times; hypoxic brain damage by 1,2 times. Field of Application: Oncology, anesthesiology, intensive care.
Product Description
popup.authors
Volkova Yuliya Viktyorivna
Pavlichenko Yuliana V.
Pylypenko Serhii O.
Revenkova Svitlana I.
Tepla Viktoriia O.
Tretiak Maryna Yu.
popup.nrat_date
2024-12-25
